Footnotes
1Data provided by the Institute for Health Metrics and Evaluation, 2022.
2Kaiser Permanente has superior screening rates compared to the national average for 3 of the most common types of cancer: breast, cervical, and colorectal. Based on 2023 HEDIS® scores, Kaiser Permanente 2023 HEDIS® Benchmarks provided by the National Committee for Quality Assurance (NCQA) Quality Compass® and represent all lines of business. Kaiser Permanente combined region scores were provided by the Kaiser Permanente Department of Care and Service Quality. The source for data contained in this publication is Quality Compass 2023 and is used with the permission of NCQA. Quality Compass 2023 includes certain CAHPS data. Any data display, analysis, interpretation, or conclusion based on these data is solely that of the authors, and NCQA specifically disclaims responsibility for any such display, analysis, interpretation, or conclusion. Quality Compass® and HEDIS® are registered trademarks of NCQA. CAHPS® is a registered trademark of the Agency for Healthcare Research and Quality.
3Erin E. Hahn, PhD, MPH, et al., “Incidence and Survival for Patients Diagnosed With Breast, Colorectal, and Lung Cancer in an Integrated System,” The Permanente Journal, September 19, 2023. Age-standardized, 5-year survival rates for Kaiser Permanente members diagnosed with breast, colorectal, lung, and cervical cancer, for cases diagnosed in 2013, compared with the Surveillance, Epidemiology, and End Results (SEER) national benchmark survival rates.
4Classes vary by location. Some members may have to pay a fee for certain classes.